BioCentury
ARTICLE | Financial News

Caxton Advantage launches independent firm

February 24, 2012 2:28 AM UTC

Life science investment firm Caxton Advantage Venture Partners announced the formation of Valence Life Sciences, an independent investment firm focused on private and micro-cap public clinical-stage l...